- Home
- BFRG vs NVNO Comparison
BFRG vs NVNO Comparison
Compare BFRG & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- NVNO
- Stock Information
- Founded
- BFRG 2017
- NVNO 1987
- Country
- BFRG United States
- NVNO United States
- Employees
- BFRG N/A
- NVNO N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- NVNO Medical/Dental Instruments
- Sector
- BFRG Technology
- NVNO Health Care
- Exchange
- BFRG Nasdaq
- NVNO Nasdaq
- Market Cap
- BFRG 15.4M
- NVNO 16.7M
- IPO Year
- BFRG 2023
- NVNO N/A
- Fundamental
- Price
- BFRG $1.50
- NVNO $0.75
- Analyst Decision
- BFRG
- NVNO
- Analyst Count
- BFRG 0
- NVNO 0
- Target Price
- BFRG N/A
- NVNO N/A
- AVG Volume (30 Days)
- BFRG 447.2K
- NVNO 413.8K
- Earning Date
- BFRG 11-07-2025
- NVNO 10-31-2025
- Dividend Yield
- BFRG N/A
- NVNO N/A
- EPS Growth
- BFRG N/A
- NVNO N/A
- EPS
- BFRG N/A
- NVNO N/A
- Revenue
- BFRG $33,257.00
- NVNO N/A
- Revenue This Year
- BFRG N/A
- NVNO N/A
- Revenue Next Year
- BFRG N/A
- NVNO N/A
- P/E Ratio
- BFRG N/A
- NVNO N/A
- Revenue Growth
- BFRG N/A
- NVNO N/A
- 52 Week Low
- BFRG $1.09
- NVNO $0.67
- 52 Week High
- BFRG $4.84
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- BFRG 55.21
- NVNO 31.87
- Support Level
- BFRG $1.45
- NVNO $0.74
- Resistance Level
- BFRG $1.70
- NVNO $0.82
- Average True Range (ATR)
- BFRG 0.15
- NVNO 0.07
- MACD
- BFRG -0.00
- NVNO 0.04
- Stochastic Oscillator
- BFRG 28.79
- NVNO 21.74
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.